• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New Alzheimer’s Association report reveals one in three seniors dies with dementia

New Alzheimer’s Association report reveals one in three seniors dies with dementia

March 19, 2013
CenterWatch Staff

According to the Alzheimer's Association’s just released 2013 Alzheimer's Disease Facts and Figures report, one in three U.S. seniors dies with Alzheimer’s or another dementia.

The report shows while deaths from other major diseases, such as heart disease, HIV/AIDS and stroke, continue to experience significant declines, Alzheimer’s deaths continue to rise—up 68% from 2000 to 2010.

“Unfortunately, today there are no Alzheimer’s survivors. If you have Alzheimer's disease, you either die from it or die with it,” said Harry Johns, president and CEO of the Alzheimer’s Association. “Urgent, meaningful action is necessary, particularly as more and more people age into greater risk for developing a disease that today has no cure and no way to slow or stop its progression.”

Alzheimer’s disease is the sixth-leading cause of death in the U.S. and is the only leading cause of death without a way to prevent, cure or even slow its progression. Based on 2010 data, Alzheimer’s was reported as the underlying cause of death for 83,494 individuals—those who died from Alzheimer’s. The reportreveals that in 2013 an estimated 450,000 people in the U.S. will die with Alzheimer’s.

A recent study evaluated the contribution of individual common diseases to death using a nationally representative sample of older adults and found dementia was the second largest contributor to death behind heart failure. Among 70 year olds with Alzheimer’s, 61% are expected to die within a decade. Among 70 year olds without Alzheimer’s, only 30% will die within a decade.

More than 5 million Americans are living with Alzheimer’s. Without medical breakthroughs to prevent, slow or stop the disease, by 2050 the number could reach 13.8 million. Previous estimates suggest up to 16 million.

“With baby boomers reaching the age of elevated risk, we do not have time to do what we have always done,” said Robert Egge, vice president of public policy for the Alzheimer’s Association. “The National Institutes of Health needs to reset its priorities and focus its resources on the crisis at our doorstep, and Congress must fully fund implementation of the National Alzheimer’s Plan to solve the crisis.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing